Guided Therapeutics (GTHP) Stock Chart & Stock Price History $0.27 +0.03 (+12.50%) As of 12:55 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Guided Therapeutics Stock Price Performance The Guided Therapeutics (GTHP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 54.29%, with a year-to-date return of 80.00%. In the past month, the stock has decreased 3.40%, reflecting recent market activity. As of the latest close, Guided Therapeutics traded at $0.27 with a market cap of $22.57 million and volume of 2,000 shares. Five years ago, the stock traded at $0.27, representing a 0.74% decrease over that period. At the time, it had a market cap of $3.56 million and a volume of 1,014 shares. Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+12.50%1 Month Performance-3.40%3 Month Performance+1.69%Year-To-Date Performance+80.00%1 Year Performance+54.29%5 Year Performance-0.74% GTHP Stock Chart for Thursday, October, 2, 2025 GTHP Chart by TradingView Guided Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/02/2025$0.27$0.27$0.27$0.27501 shs$22.57 million10/01/2025$0.24$0.27+12.50%$0.27$0.272,000 shs$22.57 million09/30/2025$0.24$0.24$0.24$0.2412,000 shs$20.06 million09/29/2025$0.24$0.24$0.24$0.2421,357 shs$20.06 million09/26/2025$0.26$0.24-5.88%$0.24$0.2421,357 shs$20.06 million09/25/2025$0.27$0.26-5.56%$0.26$0.2419,432 shs$21.32 million09/24/2025$0.28$0.27-3.57%$0.28$0.2730,908 shs$22.57 million09/23/2025$0.28$0.28$0.28$0.281 shs$23.41 million09/22/2025$0.28$0.28$0.28$0.241,803 shs$23.41 million09/19/2025$0.26$0.28+6.06%$0.28$0.241,803 shs$23.41 million Get the Latest News and Ratings for GTHP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/18/2025$0.28$0.26-4.17%$0.26$0.261,031 shs$22.07 million09/17/2025$0.26$0.28+6.99%$0.28$0.286,400 shs$23.03 million09/16/2025$0.27$0.26-6.02%$0.28$0.2513,414 shs$21.53 million09/15/2025$0.27$0.27$0.27$0.27601 shs$22.91 million09/12/2025$0.28$0.27-1.97%$0.28$0.252,937 shs$22.91 million09/11/2025$0.29$0.28-3.62%$0.28$0.2420,124 shs$23.20 million09/10/2025$0.29$0.29$0.29$0.269,693 shs$24.07 million09/09/2025$0.29$0.29$0.29$0.269,693 shs$24.07 million09/08/2025$0.28$0.29+3.57%$0.29$0.2889,348 shs$24.07 million09/05/2025$0.28$0.28$0.28$0.241,360 shs$23.24 million09/04/2025$0.26$0.28+8.53%$0.28$0.25723 shs$23.24 million09/03/2025$0.28$0.26-7.69%$0.26$0.261,101 shs$21.41 million09/02/2025$0.28$0.28$0.28$0.243,245 shs$23.20 million09/01/2025$0.28$0.28$0.28$0.243,245 shs$23.20 million Related Companies Apyx Medical Stock Chart Pulmonx Stock Chart IceCure Medical Stock Chart QT Imaging Stock Chart Fractyl Health Stock Chart Plus Therapeutics Stock Chart Cytosorbents Stock Chart Daxor Stock Chart SurgePays Stock Chart TELA Bio Stock Chart Receive GTHP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GTHP) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredFree: The Crypto Summit That Could Change Your LifeFed cuts unleash crypto's next wave The smart money is already moving. This is your chance to see their car...Crypto 101 Media | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guided Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guided Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
